Literature DB >> 22789975

Genetics of Kawasaki disease: what we know and don't know.

Yoshihiro Onouchi1.   

Abstract

Kawasaki disease (KD) is a leading cause of acquired heart disease in children in developed countries. Although it has been thought that symptoms of KD are related to hyperactivation of the immune system triggered by infection with some microorganisms, the etiological agent still remains unknown. In this situation, genetic factors underlying the disease pathogenesis, which have been suggested by epidemiological findings, are expected to be clues to the enigma. Recently, susceptibility genes for KD have been identified in succession by studies with a genome-wide approach. Recent advances in genetic studies for KD will be presented.

Entities:  

Mesh:

Year:  2012        PMID: 22789975     DOI: 10.1253/circj.cj-12-0568

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  47 in total

1.  Familial Kawasaki disease and acute glomerulonephritis: case report and review of literature.

Authors:  Sarah A Salam Salih; Abdelbasit M A Elbashier; Nazik Abd Alaziz Alameen
Journal:  Sudan J Paediatr       Date:  2020

Review 2.  Kawasaki disease: insights into pathogenesis and approaches to treatment.

Authors:  Stanford T Shulman; Anne H Rowley
Journal:  Nat Rev Rheumatol       Date:  2015-04-28       Impact factor: 20.543

3.  Urotensin 2 in Kawasaki disease pathogenesis.

Authors:  Cassidy Y Huang; Jane C Burns; Chisato Shimizu
Journal:  Pediatr Res       Date:  2017-08-16       Impact factor: 3.756

Review 4.  Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.

Authors:  Jane C Burns; Isabelle Koné-Paut; Taco Kuijpers; Chisato Shimizu; Adriana Tremoulet; Moshe Arditi
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

Review 5.  Kawasaki disease: etiopathogenesis and novel treatment strategies.

Authors:  Shreya Agarwal; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2016-09-13       Impact factor: 4.473

6.  Genetic polymorphism of SMAD5 is associated with Kawasaki disease.

Authors:  Ja Hyang Cho; Mi Young Han; Sung Ho Cha; Joo Ho Jung; Kyung Lim Yoon
Journal:  Pediatr Cardiol       Date:  2013-10-26       Impact factor: 1.655

7.  Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.

Authors:  Qian Peng; Yan Deng; Xiling Yang; Xiangyou Leng; Yuan Yang; Hanmin Liu
Journal:  Eur J Pediatr       Date:  2016-02-01       Impact factor: 3.183

8.  Recognising Kawasaki disease in UK primary care: a descriptive study using the Clinical Practice Research Datalink.

Authors:  Abigail Moore; Anthony Harnden; Richard Mayon-White
Journal:  Br J Gen Pract       Date:  2014-08       Impact factor: 5.386

9.  Detection of copy number variants in African goats using whole genome sequence data.

Authors:  Wilson Nandolo; Gábor Mészáros; Maria Wurzinger; Liveness J Banda; Timothy N Gondwe; Henry A Mulindwa; Helen N Nakimbugwe; Emily L Clark; M Jennifer Woodward-Greene; Mei Liu; George E Liu; Curtis P Van Tassell; Benjamin D Rosen; Johann Sölkner
Journal:  BMC Genomics       Date:  2021-05-29       Impact factor: 3.969

10.  Associations between the spatiotemporal distribution of Kawasaki disease and environmental factors: evidence supporting a multifactorial etiologic model.

Authors:  Brian W McCrindle; Cedric Manlhiot; Tisiana Low; Brigitte Mueller; Chun-Po S Fan; Emily Somerset; Sunita O'Shea; Leonard J S Tsuji; Hong Chen
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.